Introducing TeamNemosia, the groundbreaking brand that is revolutionizing the fight against neurodegeneration. As the world's first Positron Emission Tomography (PET) Tracer targeting the NMDA receptor, we are the missing piece in early detection and understanding of neurodegenerative diseases. At TeamNemosia, we envision a world where PET scans for the early detection of neurodegeneration are the norm in everyone's regular health checkup routine.

Our cutting-edge technology combines high-resolution scanners with specific radioactive molecules, allowing us to measure a wide array of biological processes in the living human brain. With a strong patent position and successful animal studies, we are now embarking on clinical trials in humans. Our PET tracer that targets the NMDA receptor is a promising candidate for clinical translation, as highlighted by our news publications.

Led by CEO Awa Diagne and supported by a team of experts, TeamNemosia is committed to fighting neurological diseases and changing lives. Join us in this important journey and follow us on social media to stay up-to-date with the latest advancements. Partner with us in the fight against neurodegeneration and together we can make a difference.

Explore more about TeamNemosia on our website and get in touch to join our mission